Interstitial Lung Disease and Cardiotoxicity Associated with Trastuzumab Deruxtecan, Sacituzumab Govitecan, and Trastuzumab Emtansine: A Narrative Review

Raul Tirinescu, Ana-Maria Pah, Adina Tirinescu, Diana-Maria Mateescu, Camelia-Oana Muresan

Open source

DOI
10.3390/medicina62091664
Published
2026-08-30
Container
Medicina
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/medicina62091664,
  title = {Interstitial Lung Disease and Cardiotoxicity Associated with Trastuzumab Deruxtecan, Sacituzumab Govitecan, and Trastuzumab Emtansine: A Narrative Review},
  author = {Raul Tirinescu and Ana-Maria Pah and Adina Tirinescu and Diana-Maria Mateescu and Camelia-Oana Muresan},
  year = {2026},
  journal = {Medicina},
  doi = {10.3390/medicina62091664},
  url = {https://doi.org/10.3390/medicina62091664}
}

RIS

TY  - JOUR
TI  - Interstitial Lung Disease and Cardiotoxicity Associated with Trastuzumab Deruxtecan, Sacituzumab Govitecan, and Trastuzumab Emtansine: A Narrative Review
AU  - Raul Tirinescu
AU  - Ana-Maria Pah
AU  - Adina Tirinescu
AU  - Diana-Maria Mateescu
AU  - Camelia-Oana Muresan
PY  - 2026
JO  - Medicina
DO  - 10.3390/medicina62091664
UR  - https://doi.org/10.3390/medicina62091664
ER  - 

APA

Tirinescu, R., Pah, A., Tirinescu, A., Mateescu, D., & Muresan, C. (2026). Interstitial Lung Disease and Cardiotoxicity Associated with Trastuzumab Deruxtecan, Sacituzumab Govitecan, and Trastuzumab Emtansine: A Narrative Review. Medicina. https://doi.org/10.3390/medicina62091664

Source records